On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Opsona Therapeutics Limited's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€2.2M · 1 project
- Horizon 2020€0 · 1 project
Projects
2 EU-funded projects, newest first. Opsona Therapeutics Limited led 1 of them as coordinator. Each links to the official record.
- TRACTPartner
Training in Cancer Mechanisms and Therapeutics
Horizon 2020 · 2016–2020 · Project on CORDIS ↗
- MABSOTCoordinator
Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€2.2Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Almac Diagnostic Services LimitedUnited Kingdom · 2 shared projects
- Katholieke Universiteit LeuvenBelgium · 1 shared project
- King'S College LondonUnited Kingdom · 1 shared project
- The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinIreland · 1 shared project
- University of Newcastle Upon TyneUnited Kingdom · 1 shared project
- Academisch Ziekenhuis GroningenNetherlands · 1 shared project
- The Queen'S University of BelfastUnited Kingdom · 1 shared project
- Universitat de ValenciaSpain · 1 shared project
- Universita Degli Studi di SienaItaly · 1 shared project
- Fundacio Institut D'Investigacio Biomedica de BellvitgeSpain · 1 shared project
- Institut Catala de la SalutSpain · 1 shared project
- National Institute for Bioprocessing Research and Training LimitedIreland · 1 shared project
- Institut klinické a experimentální medicinyCzech Republic · 1 shared project
- Euram LimitedUnited Kingdom · 1 shared project
- OROBOROS INSTRUMENTS GmbHAustria · 1 shared project
- Andor Technology LimitedUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- drug discovery
- drug resistance
- medicinal chemistry
- prostate cancer
- surgery
- transplantation
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗